dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dímetýl fúmarat - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
nystatin orifarm mixtúra, dreifa 100.000 a.e./ml
orifarm generics a/s - nystatinum inn - mixtúra, dreifa - 100.000 a.e./ml
tibolon orifarm tafla 2,5 mg
orifarm generics a/s - tibolonum inn - tafla - 2,5 mg
spirix tafla 50 mg
orifarm healthcare a/s - spironolactonum inn - tafla - 50 mg
spirix tafla 25 mg
orifarm healthcare a/s - spironolactonum inn - tafla - 25 mg
afipran tafla 10 mg
orifarm healthcare a/s - metoclopramidum hýdróklóríð - tafla - 10 mg
levaxin tafla 0,05 mg
orifarm healthcare a/s - levothyroxinum natríum - tafla - 0,05 mg
levaxin tafla 0,1 mg
orifarm healthcare a/s - levothyroxinum natríum - tafla - 0,1 mg
nitroglycerin dak tungurótartafla 0,25 mg
orifarm healthcare a/s - glyceryl trinitrate - tungurótartafla - 0,25 mg
nitroglycerin dak tungurótartafla 0,5 mg
orifarm healthcare a/s - glyceryl trinitrate - tungurótartafla - 0,5 mg